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ABSTRACT 
Framework: glaucoma is one of the main causes for irreversible blindness. Proper treatment requires high levels of compliance to 
therapeutics. Most glaucoma patients do not comply with their treatment and that has been correlated with glaucoma progression. 
Aim: to evaluate patient’s compliance to glaucoma therapeutics. Methodology: an observational, cross-sectional and descriptive 
study was developed. Outpatients with glaucoma were enrolled and screened before follow-up medical appointment with an 
observational grid while applying antiglaucomatous drugs. After the treatment, patients were interviewed to understand their skills 
and difficulties in performing glaucoma treatment. Results: from 51 outpatients enrolled, 39% of them did not know the 
medication’s name used; 59% did not perform hand washing prior to the procedure; 73% leaned the vial tip contacting the eye; 
25% did not apply the medication to the conjunctival sac; in 63% of the subjects used more than one drop; the majority of patients, 
57%, did not wait the appropriate time between applications when two or more drugs were prescribed. Conclusion: the results 
suggest the need to implement individual or group strategies that enable patients with glaucoma to correctly perform their 
treatment. 
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RESUMO 
Enquadramento: o glaucoma é uma das principais causas de cegueira irreversível. O 
tratamento adequado requer elevados níveis de adesão ao regime terapêutico. A maioria 
dos doentes com glaucoma não cumpre a terapêutica antiglaucomatosa o que está 
correlacionado com a progressão da doença. Objetivo: avaliar a adesão da pessoa à 
terapêutica antiglaucomatosa. Metodologia: foi desenvolvido um estudo observacional, 
transversal e descritivo. Foram incluídos e selecionados para este estudo doentes com 
glaucoma em tratamento ambulatório que, antes da consulta médica, foram avaliados 
durante a aplicação de drogas antiglaucomatosas, utilizando uma grelha de observação. Após 
o tratamento, foram entrevistados para perceber as suas habilidades e dificuldades na 
realização do tratamento. Resultados: da amostra obtida de 51 doentes, 39% desconheciam 
o nome do medicamento utilizado; 59% não realizaram a lavagem das mãos antes do 
procedimento; 73% inclinou o frasco colocando-o em contato com o olho; 25% não 
aplicavam a medicação no saco conjuntival; em 63% dos sujeitos verificou-se que utilizaram 
mais de uma gota; a maioria dos doentes, 57%, não esperou o tempo adequado entre as 
aplicações quando dois ou mais medicamentos foram prescritos. Conclusão: os resultados 
sugerem a necessidade de implementar estratégias individuais ou de grupo que possibilitem 
à pessoa com glaucoma realizar corretamente o tratamento. 
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RESUMEN 
Encuadramiento: el glaucoma es una de las principales causas de ceguera irreversible. El 
tratamiento adecuado requiere altos niveles de adhesión a la terapia. La mayoría de los 
pacientes con glaucoma no cumplen su tratamiento lo que se correlacionó con la progresión 
del glaucoma. Objetivo: evaluar la adhesión del paciente a la terapéutica del glaucoma. 
Metodología: se ha desarrollado un estudio observacional, transversal y descriptivo. Fueron 
incluidos y seleccionados pacientes con glaucoma en tratamiento ambulatorio, que antes de la 
consulta médica, se evaluaron utilizando una rejilla de observación durante la aplicación de 
drogas antiglaucomatosas. Después del tratamiento, los pacientes fueron entrevistados para 
percibir sus habilidades y dificultades en la realización del tratamiento del glaucoma. 
Resultados: de la muestras 51 pacientes , el 39% desconocía el nombre del medicamento 
utilizado; 59% no realizaron el lavado de las manos antes del procedimiento; el 73% inclinó el 
frasco colocándolo en contacto con el ojo; el 25% no aplicaba la medicación en el saco 
conjuntival; en el 63% de los sujetos, se verificó que utilizaron más de una gota; la mayoría de 
los pacientes, el 57%, no esperó el tiempo adecuado entre las aplicaciones cuando se 
prescribieron dos o más medicamentos. Conclusión: los resultados sugieren la necesidad de 
implementar estrategias individuales o de grupo que posibiliten la persona con glaucoma 
realizar correctamente el tratamiento. 
Palabras clave: adhesión al tratamiento; terapéutica; glaucoma; enfermería 
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INTRODUTION 
Compliance to therapeutics has a key role to improve 
quality of life for patients with chronic disease and in 
glaucoma patients it is known to be poor. There are 
no available data concerning patient’s compliance to 
eye drop treatment amongst Portuguese glaucoma 
patients. This has been identified has a problem and it 
is the focus of this research. With the aim of 
determining glaucoma patient’s compliance to 
treatment, an observational, cross-sectional and 
descriptive study was developed in a Portuguese 
public hospital.  The knowledge about compliance to 
the therapeutic regimen and the identification of 
possible barriers or constraints will allow nurses to 
intervene in this area, providing personalized care, 
more responsive to the real needs of these patients.  
 
BACKGROUND / THEORETICAL FRAMEWORK 
Glaucoma is one of the main causes for irreversible 
blindness in the world (Quigley & Broman, 2006; 
Weinreb, Aung & Medeiros, 2014; World Health 
Organization, 2012), caused by optic neuropathies 
characterized by retinal ganglion cells progressive 
degeneration (Weinreb, Aung & Medeiros, 2014). In 
Portugal, more than 200.000 people have intraocular 
hypertension and, of those, one third suffers from 
glaucoma. Around 6.000 patients can evolve to 
irreversible blindness or marked vision degradation 
(Direção-Geral da Saúde, 2016) and 2.2% (231,634 
inhabitants) of Portuguese population are under some 
type of eye drop treatment (Sousa et al., 2017). 
Glaucoma treatment includes medical treatment, 
laser therapy and surgery, or their combination 
(Boland et al., 2013). Medical treatment with 
hypotensive drops is the most frequently used 
approach, with effective results in decreasing 
intraocular pressure (Weinreb et al., 2014) and the 
first choice in Portuguese guidelines  for glaucoma 
therapeutics (Direção-Geral da Saúde, 2014). 
However, proper treatment requires high levels of 
compliance to therapeutics (Prum Jr. et al., 2016). 
Compliance to medical treatment is poor, having up 
to 80% of glaucoma patients that do not comply with 
their medication regimen (Olthoff, Schouten, Van de 
Borne & Webers, 2005). This has been shown to be 
correlated with glaucoma progression (Sleath et al., 
2011), and should be a main concern to health 
professionals. Four groups of presumed determinants 
were identified for noncompliance in glaucoma 
patients: demographic and sociographic variables; 
knowledge, attitude, and health behavior–related 
variables; aspects of the disease; and aspects of the 
treatment (Olthoff, Schouten, Van de Borne & 
Webers, 2005). Health professionals must target their 
interventions to enhance compliance of patients in 
whom they expect clinically relevant noncompliance, 
focusing on patient knowledge and understanding of 
glaucoma, patient forgetfulness, and reduction of the 
dose frequency (Olthoff, Schouten, Van de Borne & 
Webers, 2005). .  
 
METHODOLOGY 
For this observational, cross-sectional and descriptive 
study, 51 adult patients diagnosed with glaucoma and 
ocular hypotensive treatment were enrolled, after 
informed consent, from both genders, treated as 
outpatients, in an ophthalmology department of a 
major public hospital. All data collection and 
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treatment had prior approval by the hospital’s ethic 
commission.  
Data collection was carried between April and May of 
2017, through structured observation and systematic 
description of behaviours and events that concern the 
research problem. At the hospital where this study 
was conducted, there is no structured educational 
program for glaucoma patients. Study’s Inclusion 
criteria were: 1) outpatients at the hospital’s 
ophthalmology clinic, 2) cognitive and mental abilities 
to respond to the posed questions and to 
autonomously perform eye drop treatment, 3) to be 
an adult, and 4) informed consent to participate in the 
study. An observation grid was constructed by the 
authors, according to good practice standards and 
literature review, to allow data collection and 
analysis, namely behavioural data regarding the steps 
necessary to correctly perform the eye drop applying 
technique (Ministério da Saúde, 2011). Patients were 
asked to demonstrate how they normally apply ocular 
medication using a sterile artificial tear flask. During 
that, researchers observed and registered if the 
procedure was performed correctly, with the 
observational grid, according to the following items: 
1) hand washing before procedure 2) head positioning 
3) contact between the eye and the vial 4) eye 
location for drop application (conjunctival sac or 
elsewhere) 5) number of drops by application and 6) 
hand washing after the procedure. After therapeutics 
procedure, patients were interviewed, through a 
structured interview, to understand their skills and 
difficulties in performing glaucoma treatment, with 
three questions: 1) medication’s name, 2) 
medication’s schedule and 3) time between 
applications if two or more eye drops were 
prescribed. 
The sample was accidental non-probabilistic, since the 
data collection was performed on a population of 
patients who had scheduled glaucoma follow-up 
appointments and met the inclusion criteria. During 
time foreseen for data collection, a total of 51 
patients was recruited. All the data were collected by 
a single researcher with differentiated training for this 
purpose. All ethical procedures have been complied 
with during data collection. Data were treated 
through descriptive statistics through the SPSS 
Version 24.  
 
RESULTS 
The sample comprised 51 patients, with 27 females 
and 24 males, with an average age of 73.4 (SD 10.5) 
and 73.7 yrs (SD 10.6) respectively, basic schooling 
(4th and 12th degree). Regarding the data collected 
from the observational grid, results show that most 
patients, 59% of the sample, did not wash their hands 
prior to the procedure. With respect to neck 
hyperextension, patients are fully aware of the 
importance of the head positioning (90%) for the 
correct eye drop application. During the drug 
instillation, it was found that 73% of patients lean the 
vial contacting with the eye. 25% of the patients did 
not apply the drop to the conjunctival sac, which 
means that the medication was not fully instilled. It 
should be noted that during the procedure these 
patients do not have the perception that eye drop 
application is not being correctly performed.  Since 
the correct use is a single eye drop, in 63% of the 
subjects it was verified that they used more than one  
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drop. It was also observed that 98% of patients do not 
wash their hands after procedure. A majority of 57% 
patients did not wait for the appropriate time for 
effective treatment in case of prescription of two or 
more drugs. 
Results from the structured interview show that 39% 
of the subjects did not know the name of the drug 
used, which may cause some difficulty in the 
treatment and recognition of the disease. Regarding 
the schedule of the application of the medication by 
the patient, it was verified that 96% of them are in 
compliance with the prescribed schedule. In our 
study, only 4% of the patients did not know the time 
for medication application.  
 
DISCUSSION 
The results obtained suggest that it is necessary to 
improve compliance in glaucoma patients treated 
with ocular hypotensive therapeutics. This study 
reinforces previous findings from other studies that 
evaluated compliance in glaucoma patients (Muir & 
Lee, 2011; Vaidergorn et al., 2003). Intraocular 
pressure control depends greatly on the strict 
compliance with eye drop treatment, not only in 
terms of periodicity, but also with respect to 
compliance with the rules for the eye drop application 
(Robin & Grover, 2011).  
Regarding knowledge about prescription, 39% of 
patients did not know the medication’s name and 
only 4% did not know the application schedule, which 
is in agreement with evidenced results (Tatham, 
Sarodia, Gatrad & Awan, 2013).  One of the aspects to 
consider is the issue of hand hygiene before and after 
procedures as a way to prevent contamination of the 
bottles and infection’s transmission (Ministério da 
Saúde, 2011). In this case, patients should be 
informed so that they are trained and adopt more 
appropriate measures. This procedure is important to 
avoid contamination of other vials, surfaces, or 
disease transmission to other people. In eye drop 
application technique, a detail such as the neck 
hyperextension is an important strategy for the 
procedure’s success which, according to the standard, 
facilitates its execution (Ministério da Saúde, 2011). 
10% of patients do not perform hyperextension, so 
educational strategies must be taken to enhance 
patients understanding of the importance of 
positioning to optimize the eye drop application. 73% 
of patients touch the vial tip to the eye surface, and it 
should be noted that some patients have rubbed the 
vial tip with some pressure on the ocular surface, 
which can lead to trauma and contamination (Tatham 
et al., 2013). Improper administration technique can 
compromise health care outcomes since it does not 
allow to fully achieve expected results with treatment. 
Recent studies have shown that improper eye drop 
administration technique can lead to bottle tip 
contamination (Kholdebarin, Campbell, Jin & Buys, 
2008; Tatham et al., 2013). The eye drop application 
to the conjunctival sac (25% did not do so) is essential 
so that medication is correctly absorbed and effective 
treatment is assured. Regarding the amount of drops 
used for each application, it should be noted that 63% 
of patients applies more than one drop, with waste, 
which for several reasons, is a factor to be taken into 
account in patient’s education, alerting that excessive 
quantity does not yield more effective results, and 
increases the cost. It is noteworthy that several 
patients literally squeeze the bottle without having 
the least notion of the amount of drops they apply, 
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stopping only when they feel the medication trickling 
on the face. Finally, 57% of patients do not wait 5 
minutes between different applications of eye drops 
in the same eye, which may reduce the efficacy of the 
medication administered and its consequent effect.  
Patient education on the eye drop application 
technique is associated with increased patient’s ability 
to correctly administer therapy. There is evidence that 
educational programs targeting glaucoma patients are 
effective (Newman-Casey, Dayno & Robin, 2016), not 
only to save costs related to over consumption of 
medication, but mainly by improving the quality of life 
of patients by obtaining better results in the control of 
intraocular pressure and consequently restrain the 
progression of the disease. Patient compliance is 
extremely important for effective and successful 
treatment. Additionally, maximizing patient 
adherence has a societal benefit (Osterberg & 
Blaschke, 2005). Poor adherence to medication has 
been shown to increase healthcare costs in the United 
States. According to Osterberg & Blaschke (2005), of 
all medication related hospital admissions in the US, 
33-69% are due to poor medication adherence, with a 
resultant cost of around $100 billion a year. 
It must be highlighted that even patients with 
previous experience in the administration of this type 
of medication continue to have difficulties in 
administering the medication (Slota et al., 2015). 
Thus, the observational grid used in this study can be 
useful to evaluate the needs of each patient and serve 
as a way to evaluate educational intervention 
outcomes over time. It has been referred the 
importance of correct use of the prescribed 
medication, not only in the use of eye drop at the 
recommended times, but also the correct application 
technique (Vaidergorn et al., 2003). The authors 
emphasize that it is extremely important that 
therapeutic compliance is effective, not only for its 
impact on the patient’s quality of life, but also for the 
monetary costs that treatment entails. In a previous 
study, more than 50% of patients did not demonstrate 
compliance or adequate administration technique, 
emphasizing that patients with glaucoma should be 
educated about the importance of compliance and 
educated about the proper eye drop administration 
technique (Tatham et al., 2013). It has been targeting 
a better compliance that education programs have 
been implemented in many places, in order to avoid 
the disease progression (Leitão et al., 2010). The 
interventions that successfully improved glaucoma 
medication compliance used an adequate face-to-face 
counselling to overcome barriers to health behaviour 
change alongside with education about glaucoma 
(Newman-Casey et al., 2016). 
This study’s results, although its time and sample 
limitations, suggests that professional behaviour 
adjustments towards patients’ needs are essential.  
 
CONCLUSION 
The results of this study provide new information 
targeting the need to promote educational programs 
for glaucoma patients, aiming to improve treatment 
compliance and health related outcomes. The 
methodology used allowed the identification of 
factors that could hardly be reached through other 
strategies of data collection. Participant observation 
suggests to be an adequate tool to deepen the 
phenomenon under study. Nevertheless, given the 
hospital’s dynamics, it would be important to develop 
simpler tools that require less time and resources for 
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continuous monitoring of educational programs and 
thus achieve the goal to have educated patients. The 
study has limitations. The single location for data 
collection has limited the sample and the fact that 
researchers had not access to the information about 
the patient’s length of treatment is the main 
limitations. Further studies should be conducted, with 
larger samples, increasing the data on patient 
compliance in glaucoma treatment, allowing more 
robust results for the design of educational programs. 
Action research must be undertaken to validate the 
results of educational programs, targeting glaucoma 
patient’s compliance. 
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